A leader in micro market technology, servicing markets in North America, Europe, Asia and Australia, Three Square Market has been infamous in microchipping willing employees, and is set to take its technology to the next level.
Developing a new chip which will be powered by body heat, according to CNBC, the business will harness GPS technology and voice recognition software, and are looking to utilise the technology to support the healthcare sector and give vulnerable patients and their families greater reassurance.
At present, employees can use their RFID chip to open doors, log in to computers, and purchase snacks, with no GPS technology placed within the software.
If approved by the Food and Drug Administration (FDA), the new chip could become a potential gamechanger.
- GlucoMe and Merck partner in a new digital diabetes management project
- Top 10 healthcare disruptors
- Life science supply chain firm Tracelink raises $93mn in new funding
“It’s not only GPS and voice activation, it’s working on monitoring your vital signs, and there are different medical institutions that obviously want that,” said Patrick McMullan, President of Three Square Market and chip technology business Three Square Chip.
The technology could provide greater support to those with dementia and Alzheimer’s and provide a greater support to families and care givers.
In the upcoming months, the company has confirmed to Technology Review that it will be working with two hospitals, where healthcare professionals will be given chipped bracelets to wear, which will note when they are washing their hands, as a basic trial.
“You see a lot of discussion now about implants, and how they can take your heartbeat, get your blood glucose levels — you see Amazon just hiring a top-notch doctor, you see Walmart filing for patents on this.
“What we’ve really done is made it acceptable, or brought it to the forefront where people are now talking about it and looking at the benefits it can do for a person,” added Three Square Market Chief Executive Officer, Todd Westby.